Phase I Study of Emactuzumab Single Agent or in Combination with Paclitaxel in Patients with Advanced/Metastatic Solid Tumors Reveals Depletion of Immunosuppressive M2-like Macrophages
Gomez-Roca, C A, Italiano, A, Le Tourneau, C, Cassier, P A, Toulmonde, M, D’Angelo, S P, Campone, M, Weber, K L, Loirat, D, Cannarile, M A, Jegg, A -M, Ries, C, Christen, R, Meneses-Lorente, G, Jacob,Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz163
Date:
May, 2019
File:
PDF, 937 KB
2019
File converter
More search results
More benefits 
